Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $653.81 | 18 | 59.4% |
| Travel and Lodging | $320.60 | 1 | 29.1% |
| Education | $126.32 | 8 | 11.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teleflex LLC | $439.90 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $195.77 | 4 | $0 (2021) |
| Myriad Genetic Laboratories, Inc. | $185.12 | 3 | $0 (2024) |
| Augmenix, Inc. | $74.36 | 1 | $0 (2018) |
| Laborie Medical Technologies Corp. | $59.44 | 3 | $0 (2023) |
| ABBVIE INC. | $36.94 | 2 | $0 (2024) |
| Boston Scientific Corporation | $29.98 | 1 | $0 (2022) |
| PFIZER INC. | $22.60 | 2 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $20.72 | 1 | $0 (2017) |
| UROVANT SCIENCES INC | $17.26 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $560.05 | 6 | Teleflex LLC ($439.90) |
| 2023 | $150.19 | 4 | Myriad Genetic Laboratories, Inc. ($90.75) |
| 2022 | $60.39 | 4 | Boston Scientific Corporation ($29.98) |
| 2021 | $89.99 | 1 | Astellas Pharma US Inc ($89.99) |
| 2020 | $11.10 | 1 | PFIZER INC. ($11.10) |
| 2019 | $105.94 | 6 | Astellas Pharma US Inc ($90.26) |
| 2018 | $91.19 | 3 | Augmenix, Inc. ($74.36) |
| 2017 | $31.88 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($20.72) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Teleflex LLC | UROLIFT (Device) | Travel and Lodging | In-kind items and services | $320.60 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/13/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/12/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $97.90 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 11/07/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $80.63 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/02/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $90.75 | General |
| Category: ONCOLOGY | ||||||
| 09/21/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $22.56 | General |
| 06/21/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $12.87 | General |
| 05/20/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| 07/18/2022 | Boston Scientific Corporation | rezum Generator (Device) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: rezum_URO | ||||||
| 05/12/2022 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $9.33 | General |
| 04/12/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Urology | ||||||
| 02/14/2022 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 01/15/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.99 | General |
| 02/04/2020 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 11/06/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $78.43 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $11.50 | General |
| Category: ONCOLOGY | ||||||
| 03/04/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $2.33 | General |
| Category: Kidney Stones | ||||||
| 03/04/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $1.31 | General |
| Category: Kidney Stones | ||||||
| 03/04/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $0.54 | General |
| Category: Kidney Stones | ||||||
| 02/20/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $15.52 | General |
| Category: ONCOLOGY | ||||||
| 09/21/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $1.31 | General |
| Category: Kidney Stones | ||||||
| 01/24/2018 | Augmenix, Inc. | SpaceOAR (Device) | Food and Beverage | In-kind items and services | $74.36 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,477 | 1,956 | $602,783 | $151,567 |
| 2022 | 26 | 1,422 | 1,854 | $607,506 | $171,562 |
| 2021 | 23 | 1,751 | 3,928 | $469,172 | $136,504 |
| 2020 | 27 | 1,859 | 4,699 | $470,954 | $154,014 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 100 | 117 | $56,277 | $15,667 | 27.8% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 55 | 55 | $36,135 | $10,276 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 126 | $30,492 | $8,433 | 27.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 57 | 57 | $31,692 | $6,661 | 21.0% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2022 | 11 | 11 | $20,262 | $6,053 | 29.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 39 | 46 | $21,525 | $5,408 | 25.1% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 15 | 16 | $17,865 | $5,268 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $13,826 | $3,605 | 26.1% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2022 | 12 | 40 | $9,440 | $2,868 | 30.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 23 | 62 | $10,416 | $2,648 | 25.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 55 | 55 | $8,635 | $2,585 | 29.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 21 | $7,476 | $2,258 | 30.2% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2022 | 11 | 11 | $7,139 | $1,857 | 26.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 14 | 51 | $4,539 | $1,398 | 30.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $4,186 | $1,159 | 27.7% |
| 55876 | Placement of device in prostate for radiation therapy | Office | 2022 | 16 | 16 | $6,528 | $1,121 | 17.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 32 | 33 | $4,983 | $1,089 | 21.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 278 | 447 | $3,576 | $977.15 | 27.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 16 | 28 | $2,856 | $859.21 | 30.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 87 | 108 | $3,024 | $826.65 | 27.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 11 | 13 | $806.00 | $228.21 | 28.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 66 | 70 | $350.00 | $210.00 | 60.0% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 13 | 13 | $459.00 | $89.04 | 19.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 266 | 328 | $108,568 | $29,345 | 27.0% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 115 | 148 | $93,092 | $28,121 | 30.2% |
About Dr. David Hutton, MD
Dr. David Hutton, MD is a Urology healthcare provider based in Walla Walla, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932113347.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hutton, MD has received a total of $1,101 in payments from pharmaceutical and medical device companies, with $560.05 received in 2024. These payments were reported across 27 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($653.81).
As a Medicare-enrolled provider, Hutton has provided services to 6,509 Medicare beneficiaries, totaling 12,437 services with total Medicare billing of $613,646. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Walla Walla, WA
- Active Since 07/28/2006
- Last Updated 06/01/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1932113347
Products in Payments
- UROLIFT (Device) $439.90
- PROLARIS (Device) $185.12
- XTANDI (Drug) $117.28
- SpaceOAR (Device) $74.36
- rezum Generator (Device) $29.98
- LUPRON DEPOT (Drug) $25.78
- Xofigo (Drug) $20.72
- GEMTESA (Drug) $17.26
- Lupron (Drug) $11.16
- TOVIAZ (Drug) $11.10
- (815) Thiola (Drug) $5.49
- Thiola (Drug) $3.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.